Filing Details
- Accession Number:
- 0001209191-20-019489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-17 11:58:12
- Reporting Period:
- 2020-03-16
- Accepted Time:
- 2020-03-17 11:58:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1698751 | T. Michael Andriole | 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-16 | 33,300 | $1.43 | 149,729 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.46, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- Includes 16,429 shares acquired under the Chimerix Employee Stock Purchase Plan on March 10, 2020.
Billionaire Hedge Funds
